Work in progress: transcatheter management of primary carcinoma of the liver.

Abstract

Patients (24) with hepatocellular carcinoma or cholangiocarcinoma were treated with hepatic artery infusion (HAI) of chemotherapeutic agents (14 patients) or hepatic artery embolization (HAE) (11 patients). One patient had a combination of the 2 treatments. Ten of the 14 (71%) patients who underwent HAI demonstrated partial remission. The median survival time was 12.3 mo. Six of the 9 patients (67%) who underwent HAE and for whom follow-up was available responded to treatment. The median survival time for those patients was 17.4 mo.